Arrowhead Pharmaceuticals, Inc.ARWRNASDAQ
LOADING
|||
| Metric | Sep 21 | Sep 22 | Sep 23 | Sep 24 | Sep 25 |
|---|---|---|---|---|---|
| Revenue | 138 | 243↑75.9% | 241↓1.0% | 4↓98.5% | 829↑23258.2% |
| Gross Profit | 138 | 243↑75.9% | 241↓1.0% | 4↓98.5% | 0 |
| Operating Income | -149 | -179↓19.8% | -205↓14.8% | -601↓193.2% | 98↑116.4% |
| Net Income | -141 | -176↓25.0% | -205↓16.6% | -599↓192.0% | -2↑99.7% |
| EBITDA | -133 | -162↓22.4% | -176↓8.2% | -562↓219.6% | 98↑117.5% |
| EPS Diluted | -1.36 | -1.67↓22.8% | -1.92↓15.0% | -5.00↓160.4% | -0.01↑99.8% |